Highlights
- •Despite guidelines, many health care providers are not routinely recommending HPV vaccine for 11- to 12-year-old girls or boys.
- •Health care providers perceive parental HPV vaccine hesitancy to be common.
- •Perceptions of hesitancy may discourage providers from routinely recommending HPV vaccine.
- •Providers' self-efficacy to address hesitancy may be important for improving vaccine uptake.
- •Findings highlight potential tools for more effectively counseling vaccine-hesitant parents.
Abstract
Introduction
Health care provider recommendations are critical for human papillomavirus (HPV) vaccine
uptake. We sought to describe providers' HPV vaccine recommendation practices and
explore their perceptions of parental hesitancy.
Method
A statewide sample (n = 575) of Minnesota health care providers (20% pediatricians, 47% family medicine
physicians, and 33% nurse practitioners) completed our online survey in April 2013.
Results
Only 76% of health care providers reported routinely recommending HPV vaccine for
girls ages 11 to 12 years, and far fewer (46%) did so for boys (p < .001). A majority of providers reported asking questions about parents' concerns
(74%), but many lacked time to probe reasons (47%) or believed that they could not
change parents' minds (55%). Higher levels of self-efficacy and outcome expectations
were associated with routine recommendations (p < .05).
Discussion
Findings suggest that providers' perceptions of hesitancy may discourage them from
routinely recommending the HPV vaccine. Improving providers' self-efficacy to address
hesitancy may be important for improving vaccination rates.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric Health CareAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Parental decision making about the HPV vaccine.Cancer Epidemiology, Biomarkers and Prevention. 2010; 19: 2187-2198
- HPV vaccination of boys in primary care practices.Academic Pediatrics. 2013; 13: 466-474
- Standard definitions: Final dispositions of case codes and outcome rates for surveys.6th ed. Author, Deerfield, IL2009
- Social foundations of thought and action.Prentice Hall, Englewood Cliffs, NJ1986
- Why don’t physicians follow clinical practice guidelines?.Journal of the American Medical Association. 1999; 282: 1458-1465
- FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2010; 59: 630-632
- National and state vaccination coverage among adolescents aged 13–17 years—United States, 2012.Morbidity and Mortality Weekly Report. 2013; 62: 685-693
- Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure.Pediatrics. 2010; 126: 425-433
- Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010.Pediatrics. 2013; 131: 645-651
- Understanding the reasons why mothers do or do not have their adolescent daughter vaccinated against human papillomavirus.Annals of Epidemiology. 2009; 19: 531-538
- Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.Pediatrics. 2006; 117: 1486-1493
- Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey—Teen, 2009.Clinical Pediatrics. 2011; 50: 1116-1124
- Recommendations on the use of quadrivalent human papillomavirus vaccine in males— Advisory Committee on Immunization Practices (ACIP).Morbity and Mortality Weekly Report. 2011; 60: 1705-1708
- Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt.Pediatrics. 2013; 131: 1114-1124
- Forgone vaccination during childhood and adolescence: Findings of a statewide survey of parents.Preventive Medicine. 2013; 56: 202-306
- Do correlates of HPV vaccine initiation differ between adolescent boys and girls?.Vaccine. 2012; 30: 5928-5934
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support.Journal of Biomedical Informatics. 2009; 42: 377-381
- Parent and provider perspectives on immunization: Are providers overestimating parental concerns?.Vaccine. 2014; 32: 579-584
- HPV vaccine decision making in pediatric primary care: A semi-structured interview study.BMC Pediatrics. 2011; 11: 74
- Pediatricians’ intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes.Journal of Adolescent Health. 2005; 37: 502-510
- Prevalence of parental concerns about childhood vaccines: The experience of primary care physicians.American Journal of Preventive Medicine. 2011; 40: 548-555
- Tailored and targeted health communication: Strategies for enhancing information relevance.American Journal of Health Behavior. 2003; 27: S227-S232
- Perceived need of a parental decision aid for the HPV vaccine: Content and format preferences.Health Promotion Practice. 2012; 13: 214-221
- Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).Morbity and Mortality Weekly Report. 2007; 56: 1-24
- Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study.Vaccine. 2012; 30: 1269-1275
- Validity and reliability of a survey to identify vaccine-hesitant parents.Vaccine. 2011; 29: 6598-6605
- Providers’ perceptions of parental concerns about HPV vaccination.Journal of Health Care for the Poor and Underserved. 2013; 24: 828-839
- Parents’ health beliefs and HPV vaccination of their adolescent daughters.Social Science and Medicine. 2009; 69: 475-480
- HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen.Vaccine. 2013; 31: 2816-2821
- Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate.Vaccine. 2013; 31: 3121-3125
- Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician’s recommendation.Vaccine. 2011; 29: 890-895
- A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy.Vaccine. 2013; 31: 4293-4304
U.S. Department of Health and Human Services. (2014). Healthy People 2020 objectives: Immunization and infectious diseases. Retrieved from http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=23
- Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited.Vaccine. 2011; 29: 8634-8641
- Human papillomavirus vaccination of males: Attitudes and perceptions of physicians who vaccinate females.Journal of Adolescent Health. 2010; 47: 3-11
- Cognitive interviewing: A tool for improving questionnaire design.Sage Publications, Thousand Oaks, CA2005
- Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey.American Journal of Public Health. 2013; 103: 164-169
Biography
Annie-Laurie McRee, Assistant Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH.
Biography
Melissa B. Gilkey, Postdoctoral Fellow, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Biography
Amanda F. Dempsey, Associate Professor, Children's Outcomes Research Program, University of Colorado–Denver, Denver, CO.
Article info
Publication history
Published online: July 10, 2014
Footnotes
This study was funded through a Young Investigator Award from the Academic Pediatric Association, supported by the Maternal and Child Health Bureau in partnership with the American Academy of Pediatrics (U04MC07853-03; primary investigator [PI], McRee) with further support from a National Research Service Award in Primary Medical Care from the Health Resources and Services Administration (T32HP22239; PI, Borowsky); the University of North Carolina Lineberger Cancer Control Education Program (R25 CA57726); and a Clinical and Translational Science Institute grant support (UL1RR033183) to the University of Minnesota from the National Center for Research Resources.
Conflicts of interest: ALM and MBG have no conflicts of interest to disclose. AFD serves on an advisory board for Merck, a company that manufactures human papillomavirus vaccine, although she does not receive research funding from this company.
Identification
Copyright
© 2014 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.
